ICU Medical, Inc.
ICUI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2 | $2 | $2 | $1 |
| % Growth | 5.4% | -0.9% | 73.2% | – |
| Cost of Goods Sold | $2 | $2 | $2 | $1 |
| Gross Profit | $1 | $1 | $1 | $0 |
| % Margin | 34.6% | 32.8% | 30.6% | 37.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $0 |
| Operating Income | $0 | $0 | -$0 | $0 |
| % Margin | 1.8% | 1% | -1.9% | 9.4% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | -$0 | -$0 | $0 |
| Tax Expense | $0 | -$0 | -$0 | $0 |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -4.9% | -1.3% | -3.3% | 7.8% |
| EPS | -4.83 | -1.23 | -3.11 | 4.86 |
| % Growth | -292.7% | 60.5% | -164% | – |
| EPS Diluted | -4.83 | -1.23 | -3.11 | 4.74 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 1.8% | 11.2% | 8.4% | 17% |